Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177057 · ClinicalTrials.gov registry record · NA
SMART Project in Preventing Skin Cancer
A NA study of Skin Carcinoma, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT03177057: Completed NA study of Skin Carcinoma, sponsored by Fox Chase Cancer Center.
NCT03177057 is a NA study of Skin Carcinoma that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 114 participants, below the 261-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177057, a NA study of Skin Carcinoma, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.
Primary Outcome
Multiple variable regression models will be performed to examine the effect of the intervention on the outcomes. All post-baseline outcomes will be used as dependent variables. The baseline scores, intervention group, and time of the assessment will be included. To account for the within subject correlation of the responses, we will fit the model using Generalized Estimating Equations assuming an autoregressive working correlation matrix for each subject. Any p-value from the pairwise comparison
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Health Telemonitoring
- BEHAVIORAL Compliance Monitoring
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2013-04-23 |
| Est. Completion | 2014-12-31 |
| Phase | NA |
What the finished NCT03177057 record still lists
NCT03177057 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 261-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Skin Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03177057 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03177057 about?
NCT03177057 is a clinical study titled "SMART Project in Preventing Skin Cancer". This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best preven...
What is the current status of trial NCT03177057?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2013-04-23. Estimated completion is 2014-12-31.
What conditions does trial NCT03177057 study?
This clinical trial studies the following conditions: Skin Carcinoma.
What interventions are being tested in trial NCT03177057?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Telemonitoring (OTHER), Compliance Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03177057?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03177057 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
ACTIVE NOT RECRUITING · NA
-
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
ACTIVE NOT RECRUITING · NA
-
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
COMPLETED · NA
-
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI